HomeCompareVCTY vs PFE

VCTY vs PFE: Dividend Comparison 2026

VCTY yields 10000000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VCTY wins by $4.762052817831319e+46M in total portfolio value
10 years
VCTY
VCTY
● Live price
10000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.762052817831319e+46M
Annual income
$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00
Full VCTY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — VCTY vs PFE

📍 VCTY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVCTYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VCTY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VCTY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VCTY
Annual income on $10K today (after 15% tax)
$850,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$40,476,652,714,542,950,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, VCTY beats the other by $40,476,652,714,542,950,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VCTY + PFE for your $10,000?

VCTY: 50%PFE: 50%
100% PFE50/50100% VCTY
Portfolio after 10yr
$2.3810264089156593e+46M
Annual income
$23,809,795,714,437,028,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

VCTY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-50.2
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VCTY buys
0
PFE buys
0
No recent congressional trades found for VCTY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVCTYPFE
Forward yield10000000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4.762052817831319e+46M$49.6K
Annual income after 10y$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00$26,258.71
Total dividends collected$4.762046689458665e+46M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: VCTY vs PFE ($10,000, DRIP)

YearVCTY PortfolioVCTY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$1,000,010,700$1,000,000,000.00$9,153$693.39+$1000.00MVCTY
2$93,460,013,936,683$93,458,943,925,233.62$8,593$849.25+$93460013.93MVCTY
3$8,163,259,573,940,183,000$8,163,159,571,725,270,000.00$8,336$1,066.78+$8163259573940.17MVCTY
4$666,373,880,559,373,300,000,000$666,365,145,871,629,100,000,000.00$8,437$1,384.80+$666373880559373312.00MVCTY
5$50,838,057,311,279,720,000,000,000,000$50,837,344,291,227,520,000,000,000,000.00$9,013$1,875.40+$5.083805731127972e+22MVCTY
6$3,624,737,622,195,432,400,000,000,000,000,000$3,624,683,225,474,109,500,000,000,000,000,000.00$10,306$2,680.72+$3.6247376221954326e+27MVCTY
7$241,535,451,261,763,920,000,000,000,000,000,000,000$241,531,572,792,508,160,000,000,000,000,000,000,000.00$12,820$4,101.38+$2.4153545126176394e+32MVCTY
8$15,041,872,435,857,020,000,000,000,000,000,000,000,000,000$15,041,613,992,924,168,000,000,000,000,000,000,000,000,000.00$17,673$6,826.70+$1.504187243585702e+37MVCTY
9$875,466,765,540,973,800,000,000,000,000,000,000,000,000,000,000$875,450,670,737,467,500,000,000,000,000,000,000,000,000,000,000.00$27,543$12,591.86+$8.754667655409739e+41MVCTY
10$47,620,528,178,313,184,000,000,000,000,000,000,000,000,000,000,000,000$47,619,591,428,874,056,000,000,000,000,000,000,000,000,000,000,000,000.00$49,560$26,258.71+$4.762052817831319e+46MVCTY

VCTY vs PFE: Complete Analysis 2026

VCTYStock

Videolocity International, Inc., through its subsidiaries, operates as a Chinese management education and consulting firm in the People's Republic of China. The company provides consulting, educational, and training curricula focusing on government management training, administrative party cadres training, women cadres training, councilors training, and training of Communist Party members and community neighborhood committee cadres. It also offers business management training, financial management training, training of execution, human resources training, and secretarial staff training; and college student, career guidance, on-the-job, ethics, foreign language, pre-masters degree course, and doctorate preparatory course training. In addition, the company involves in various business activities, including economic zoning, such as regional economic development planning, urban planning, land planning, and plans for the development of industries; and supplying services and planning for conferences by undertaking trade and investment promotion, product exhibitions, and various other forums. Videolocity International, Inc. is based in Henderson, Nevada.

Full VCTY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this VCTY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VCTY vs SCHDVCTY vs JEPIVCTY vs OVCTY vs KOVCTY vs MAINVCTY vs JNJVCTY vs MRKVCTY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.